Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeannette Lee

Concepts (466)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
20
2023
355
3.010
 Why?
Anus Neoplasms
10
2023
24
2.190
 Why?
Stroke
7
2024
478
1.860
 Why?
Acquired Immunodeficiency Syndrome
11
2022
52
1.650
 Why?
Prostatic Hyperplasia
10
2015
38
1.490
 Why?
Brain
9
2024
1310
1.440
 Why?
Parkinson Disease
2
2023
142
1.320
 Why?
Randomized Controlled Trials as Topic
8
2024
550
1.260
 Why?
Chlamydia Infections
8
2017
75
1.240
 Why?
Sarcoma, Kaposi
12
2022
75
1.080
 Why?
Papillomavirus Infections
5
2022
167
1.050
 Why?
Chlamydia trachomatis
6
2017
29
1.040
 Why?
Lymphoma, AIDS-Related
10
2020
16
1.010
 Why?
Plant Extracts
5
2013
166
0.940
 Why?
Brain Ischemia
2
2023
157
0.930
 Why?
Mesenchymal Stem Cell Transplantation
1
2024
17
0.920
 Why?
Humans
102
2025
49898
0.890
 Why?
Serenoa
5
2013
7
0.880
 Why?
Rural Population
4
2023
549
0.810
 Why?
Phytotherapy
3
2012
42
0.810
 Why?
Umbilical Cord
2
2020
34
0.810
 Why?
Lymphoma, Non-Hodgkin
6
2021
58
0.740
 Why?
Antineoplastic Combined Chemotherapy Protocols
12
2021
994
0.730
 Why?
Middle Aged
50
2021
12285
0.730
 Why?
Research Design
5
2022
344
0.710
 Why?
Male
61
2024
25437
0.680
 Why?
Rats
9
2024
3273
0.680
 Why?
Neonatal Abstinence Syndrome
3
2024
25
0.670
 Why?
Fetal Blood
2
2019
65
0.670
 Why?
Adult
48
2022
13346
0.650
 Why?
Infarction, Middle Cerebral Artery
4
2024
40
0.650
 Why?
Inflammation
3
2021
603
0.640
 Why?
Patient Participation
1
2018
67
0.600
 Why?
Vaginosis, Bacterial
2
2015
8
0.570
 Why?
Decision Making
1
2018
273
0.530
 Why?
Neoplasms
3
2023
1233
0.530
 Why?
Mammography
1
2016
98
0.520
 Why?
Female
48
2024
26560
0.510
 Why?
Antineoplastic Agents
9
2023
1175
0.510
 Why?
Aged
28
2020
9447
0.500
 Why?
Antibodies, Monoclonal, Murine-Derived
6
2015
47
0.490
 Why?
Animals
16
2025
13100
0.480
 Why?
Population Density
1
2014
15
0.480
 Why?
Pelvic Inflammatory Disease
2
2018
8
0.480
 Why?
AIDS-Related Opportunistic Infections
5
2016
40
0.470
 Why?
Stem Cell Transplantation
4
2025
179
0.470
 Why?
Carcinoma in Situ
3
2013
73
0.460
 Why?
Rats, Sprague-Dawley
7
2024
1578
0.450
 Why?
Cytokines
5
2023
607
0.450
 Why?
Anti-Bacterial Agents
5
2020
742
0.440
 Why?
Uterine Cervicitis
1
2013
3
0.440
 Why?
Hydrocephalus, Normal Pressure
1
2012
1
0.430
 Why?
Urethritis
2
2012
5
0.430
 Why?
Finasteride
4
2015
4
0.410
 Why?
Lymphoma, Large B-Cell, Diffuse
3
2021
103
0.410
 Why?
Research Subjects
1
2013
50
0.410
 Why?
Guideline Adherence
1
2013
134
0.410
 Why?
Subarachnoid Hemorrhage
1
2012
61
0.400
 Why?
Breast Neoplasms
3
2017
1183
0.390
 Why?
Patient Dropouts
1
2012
51
0.390
 Why?
Carcinoma, Non-Small-Cell Lung
1
2013
153
0.390
 Why?
Urologic Diseases
1
2011
10
0.380
 Why?
Analgesics, Opioid
4
2024
554
0.380
 Why?
HIV-1
6
2020
53
0.370
 Why?
Lung Neoplasms
2
2013
600
0.360
 Why?
Disease Models, Animal
5
2024
1411
0.350
 Why?
Stem Cells
3
2025
171
0.350
 Why?
United States
10
2023
4878
0.350
 Why?
Patient Selection
1
2011
254
0.340
 Why?
Young Adult
16
2018
4029
0.330
 Why?
Quality of Life
6
2024
837
0.330
 Why?
Asthma
2
2024
282
0.330
 Why?
Lymphedema
2
2022
43
0.330
 Why?
HIV Seropositivity
3
2021
27
0.330
 Why?
Lower Urinary Tract Symptoms
3
2013
6
0.330
 Why?
Intestinal Mucosa
2
2021
215
0.320
 Why?
Polymorphism, Single Nucleotide
3
2017
482
0.310
 Why?
Gonorrhea
2
2020
9
0.310
 Why?
Azithromycin
4
2020
25
0.300
 Why?
Risk Factors
8
2022
3604
0.290
 Why?
Th1 Cells
2
2017
53
0.280
 Why?
Vascular Endothelial Growth Factor A
4
2017
183
0.270
 Why?
Treatment Outcome
17
2020
5176
0.260
 Why?
Mycoplasma genitalium
2
2018
2
0.260
 Why?
Doxazosin
3
2015
3
0.260
 Why?
Mycoplasma Infections
2
2018
7
0.260
 Why?
Anti-Infective Agents
2
2020
95
0.250
 Why?
Prospective Studies
11
2022
2345
0.250
 Why?
Cyclophosphamide
9
2021
163
0.250
 Why?
Doxycycline
3
2015
33
0.250
 Why?
Cancer Vaccines
1
2006
78
0.250
 Why?
Vincristine
8
2021
84
0.250
 Why?
Multicenter Studies as Topic
4
2024
89
0.240
 Why?
Hematopoietic Stem Cell Transplantation
3
2018
554
0.240
 Why?
Circadian Rhythm
1
2025
89
0.240
 Why?
Adolescent
13
2022
6414
0.240
 Why?
Air Filters
1
2024
1
0.230
 Why?
Double-Blind Method
4
2013
679
0.230
 Why?
Thymus Gland
2
2021
42
0.230
 Why?
Air Pollution, Indoor
1
2024
25
0.230
 Why?
CD4 Lymphocyte Count
7
2020
32
0.230
 Why?
Bronchiolitis
1
2024
27
0.230
 Why?
Prevalence
6
2021
956
0.230
 Why?
5-alpha Reductase Inhibitors
2
2015
3
0.230
 Why?
Homosexuality, Male
3
2022
52
0.220
 Why?
Hyperbaric Oxygenation
1
2023
14
0.220
 Why?
Substantia Nigra
1
2023
14
0.220
 Why?
Cell Differentiation
3
2025
649
0.220
 Why?
alpha-Synuclein
1
2023
8
0.220
 Why?
Doxorubicin
8
2021
233
0.220
 Why?
Transplantation Conditioning
2
2018
82
0.220
 Why?
Nervous System Diseases
1
2024
88
0.220
 Why?
Tumor Necrosis Factor-alpha
2
2017
388
0.210
 Why?
Informatics
1
2023
8
0.210
 Why?
Prednisone
7
2021
100
0.210
 Why?
Herpesvirus 8, Human
5
2020
95
0.210
 Why?
Follow-Up Studies
8
2019
2175
0.210
 Why?
Cross-Sectional Studies
3
2021
1573
0.210
 Why?
Brachytherapy
1
2022
46
0.210
 Why?
Astrocytes
1
2024
146
0.210
 Why?
Child
8
2024
6844
0.210
 Why?
Watchful Waiting
1
2022
27
0.200
 Why?
Medical Records
1
2022
85
0.200
 Why?
Absorptiometry, Photon
1
2003
152
0.200
 Why?
Feasibility Studies
2
2021
382
0.200
 Why?
Substance Withdrawal Syndrome
1
2023
167
0.200
 Why?
Genome-Wide Association Study
3
2018
163
0.200
 Why?
Vitamin D Deficiency
1
2022
44
0.200
 Why?
Viral Load
6
2020
76
0.200
 Why?
Brain Injuries
1
2023
159
0.200
 Why?
Case-Control Studies
3
2014
1128
0.200
 Why?
Vaccines
1
2022
49
0.200
 Why?
Precancerous Conditions
1
2022
83
0.190
 Why?
Mouth Diseases
1
2021
5
0.190
 Why?
Lymphocyte Activation
3
2017
171
0.190
 Why?
Clinical Trials as Topic
5
2020
466
0.190
 Why?
Vaccination
3
2022
275
0.190
 Why?
Papillomaviridae
2
2016
102
0.190
 Why?
Mass Screening
2
2015
346
0.190
 Why?
Neoplasm Staging
4
2022
749
0.190
 Why?
Pluripotent Stem Cells
1
2021
6
0.190
 Why?
Physical Conditioning, Animal
1
2021
51
0.190
 Why?
Primary Health Care
2
2022
362
0.180
 Why?
T-Lymphocyte Subsets
2
2017
38
0.180
 Why?
Drug Therapy, Combination
5
2015
380
0.180
 Why?
Papillomavirus Vaccines
2
2013
67
0.180
 Why?
Vagina
2
2018
44
0.180
 Why?
Etoposide
5
2021
71
0.180
 Why?
Anti-HIV Agents
3
2020
42
0.180
 Why?
Spleen
1
2021
170
0.180
 Why?
Enzyme Inhibitors
2
2016
378
0.180
 Why?
Cross-Over Studies
1
2021
223
0.180
 Why?
Genes, myc
1
2020
40
0.180
 Why?
Gene Frequency
2
2017
95
0.180
 Why?
Overweight
1
2022
213
0.180
 Why?
Transplantation, Autologous
3
2018
462
0.170
 Why?
Aged, 80 and over
5
2013
3136
0.170
 Why?
Uterine Cervical Neoplasms
1
2022
276
0.170
 Why?
Dihydroxyphenylalanine
1
2019
5
0.170
 Why?
Dopaminergic Neurons
1
2019
18
0.170
 Why?
Empathy
1
2019
46
0.160
 Why?
Ablation Techniques
1
2019
21
0.160
 Why?
Infant, Newborn
5
2024
2729
0.160
 Why?
Social Environment
1
2019
79
0.160
 Why?
Altruism
1
2018
12
0.160
 Why?
Mitochondria
2
2020
395
0.160
 Why?
Sodium, Dietary
1
2019
23
0.160
 Why?
Central Nervous System Diseases
1
2019
26
0.160
 Why?
Asymptomatic Infections
1
2018
5
0.160
 Why?
Antiviral Agents
2
2013
168
0.150
 Why?
Dopamine
1
2019
170
0.150
 Why?
Acoustic Stimulation
1
2018
97
0.150
 Why?
Sexually Transmitted Diseases
1
2018
36
0.150
 Why?
Enzyme-Linked Immunosorbent Assay
3
2017
234
0.150
 Why?
Energy Metabolism
1
2020
282
0.150
 Why?
Protein Kinase Inhibitors
2
2023
205
0.150
 Why?
Hyperthermia, Induced
1
2019
116
0.150
 Why?
Chlamydia
1
2017
8
0.150
 Why?
Mucous Membrane
1
2017
28
0.150
 Why?
Blood Cells
1
2017
43
0.150
 Why?
Biopsy
2
2022
591
0.140
 Why?
Pilot Projects
3
2019
702
0.140
 Why?
Genetic Predisposition to Disease
2
2018
507
0.140
 Why?
Clostridium Infections
1
2018
53
0.140
 Why?
Antibodies, Bacterial
1
2017
27
0.140
 Why?
DNA, Circular
1
2017
18
0.140
 Why?
Clonal Evolution
1
2017
56
0.140
 Why?
Immunoglobulins
1
2017
79
0.140
 Why?
Immunoglobulin G
1
2017
184
0.140
 Why?
Anus Diseases
1
2016
2
0.130
 Why?
Sentinel Lymph Node Biopsy
1
2017
118
0.130
 Why?
Telemedicine
1
2022
465
0.130
 Why?
Mannitol
1
2016
15
0.130
 Why?
Lymph Node Excision
1
2017
138
0.130
 Why?
Thiazoles
1
2016
53
0.130
 Why?
Guidelines as Topic
1
2016
111
0.130
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2015
8
0.130
 Why?
Diagnostic Self Evaluation
1
2015
14
0.130
 Why?
Comorbidity
2
2018
610
0.130
 Why?
Blood-Brain Barrier
1
2016
48
0.130
 Why?
Anal Canal
3
2023
21
0.130
 Why?
CD4-Positive T-Lymphocytes
1
2017
157
0.130
 Why?
Dose-Response Relationship, Drug
4
2013
1354
0.130
 Why?
Educational Status
1
2016
224
0.130
 Why?
T-Lymphocytes
1
2017
328
0.130
 Why?
Tinidazole
2
2012
2
0.130
 Why?
Burkitt Lymphoma
1
2015
26
0.120
 Why?
Imidazoles
1
2016
128
0.120
 Why?
Drug Administration Schedule
5
2020
369
0.120
 Why?
Lymph Nodes
1
2017
257
0.120
 Why?
Menarche
1
2014
7
0.120
 Why?
Stomatitis
1
2014
16
0.120
 Why?
Data Collection
3
2023
282
0.120
 Why?
Chromosomes, Human, Pair 2
1
2014
25
0.120
 Why?
Obesity
3
2022
1096
0.120
 Why?
Immunophenotyping
2
2017
109
0.120
 Why?
Disease-Free Survival
5
2016
450
0.120
 Why?
Hypogonadism
1
2013
10
0.110
 Why?
Benzamides
1
2013
50
0.110
 Why?
Incidence
4
2018
986
0.110
 Why?
Carcinoma, Squamous Cell
1
2016
330
0.110
 Why?
Health Surveys
1
2014
233
0.110
 Why?
SEER Program
1
2013
93
0.110
 Why?
Urban Population
1
2014
151
0.110
 Why?
Heart Failure
1
2019
505
0.110
 Why?
Stress Disorders, Post-Traumatic
1
2018
373
0.110
 Why?
Regenerative Medicine
2
2025
10
0.110
 Why?
Organophosphonates
1
2013
7
0.110
 Why?
Testosterone
1
2013
137
0.110
 Why?
Stress, Psychological
2
2019
258
0.110
 Why?
Perineum
1
2013
24
0.110
 Why?
DNA, Viral
3
2020
133
0.110
 Why?
Placebos
1
2013
84
0.110
 Why?
Cytosine
1
2013
30
0.110
 Why?
Adrenergic alpha-Antagonists
2
2009
27
0.110
 Why?
tau Proteins
1
2012
22
0.110
 Why?
Piperazines
1
2013
118
0.100
 Why?
Prostate
2
2015
117
0.100
 Why?
HIV
3
2023
25
0.100
 Why?
Trichomonas Infections
1
2012
2
0.100
 Why?
Trichomonas vaginalis
1
2012
3
0.100
 Why?
Transforming Growth Factor beta1
1
2012
60
0.100
 Why?
Sleep
2
2024
179
0.100
 Why?
Pyrimidines
1
2013
192
0.100
 Why?
Vulvar Neoplasms
1
2013
58
0.100
 Why?
Time Factors
5
2023
2891
0.100
 Why?
Medicare
1
2013
245
0.100
 Why?
Androgen Antagonists
1
2011
11
0.100
 Why?
Urination Disorders
1
2011
23
0.100
 Why?
Sirolimus
1
2012
62
0.100
 Why?
Antibiotics, Antineoplastic
1
2012
77
0.100
 Why?
CD8-Positive T-Lymphocytes
2
2017
124
0.090
 Why?
Kenya
2
2022
10
0.090
 Why?
Quinazolinones
1
2011
6
0.090
 Why?
Human papillomavirus 16
2
2013
44
0.090
 Why?
Practice Guidelines as Topic
1
2013
458
0.090
 Why?
Arkansas
1
2016
1987
0.090
 Why?
Social Class
1
2011
95
0.090
 Why?
Prognosis
5
2017
1956
0.090
 Why?
Multivariate Analysis
1
2012
579
0.090
 Why?
Chronic Disease
1
2012
565
0.090
 Why?
Methotrexate
2
2015
72
0.090
 Why?
Piperidines
1
2011
96
0.090
 Why?
Plant Bark
1
2009
6
0.090
 Why?
Multiple Myeloma
2
2014
2915
0.080
 Why?
Valproic Acid
1
2009
32
0.080
 Why?
Colorectal Neoplasms
1
2013
253
0.080
 Why?
Socioeconomic Factors
1
2012
583
0.080
 Why?
Ki-67 Antigen
1
2009
57
0.080
 Why?
India
2
2021
52
0.080
 Why?
Logistic Models
1
2012
895
0.080
 Why?
Fruit
1
2009
113
0.080
 Why?
Tetracyclines
2
2006
9
0.080
 Why?
Neoplasm Recurrence, Local
1
2012
626
0.080
 Why?
Cisplatin
2
2022
275
0.080
 Why?
Antiretroviral Therapy, Highly Active
3
2015
33
0.070
 Why?
Glomerulonephritis, IGA
1
2007
5
0.070
 Why?
Survival Analysis
3
2017
670
0.070
 Why?
Galactose
1
2007
28
0.070
 Why?
Glioblastoma
1
2009
88
0.070
 Why?
Immunoglobulin A
1
2007
45
0.070
 Why?
Adaptive Immunity
2
2017
31
0.070
 Why?
Sexual Partners
2
2018
29
0.070
 Why?
Disease Progression
4
2013
820
0.070
 Why?
Regression Analysis
2
2018
385
0.070
 Why?
Chaperonins
1
2006
3
0.070
 Why?
Chaperonin 60
1
2006
5
0.070
 Why?
Lymphocyte Count
1
2006
20
0.070
 Why?
Dose-Response Relationship, Immunologic
1
2006
13
0.070
 Why?
Papillomavirus E7 Proteins
1
2006
31
0.070
 Why?
Sexual Behavior
2
2018
115
0.070
 Why?
Viral Vaccines
1
2006
12
0.070
 Why?
HIV Protease Inhibitors
1
2006
2
0.070
 Why?
Immunohistochemistry
3
2017
972
0.070
 Why?
Interferon-alpha
1
2006
48
0.060
 Why?
Infant
2
2024
3572
0.060
 Why?
Nephrosis, Lipoid
1
2005
5
0.060
 Why?
Body Mass Index
2
2022
648
0.060
 Why?
Arterioles
1
2005
33
0.060
 Why?
Brain Neoplasms
1
2009
282
0.060
 Why?
Severity of Illness Index
2
2023
953
0.060
 Why?
Recombinant Fusion Proteins
1
2006
186
0.060
 Why?
Circadian Clocks
1
2025
1
0.060
 Why?
Matrix Metalloproteinase 9
3
2017
86
0.060
 Why?
Administration, Oral
4
2013
433
0.060
 Why?
Aminoimidazole Carboxamide
1
2004
3
0.060
 Why?
Administration, Intranasal
1
2024
29
0.060
 Why?
Phenotype
2
2017
728
0.060
 Why?
Leucovorin
1
2004
20
0.060
 Why?
Purines
1
2004
38
0.060
 Why?
Neutropenia
2
2020
114
0.060
 Why?
Genotype
2
2017
538
0.060
 Why?
Confidence Intervals
2
2015
154
0.060
 Why?
Dust
1
2024
22
0.060
 Why?
Carbon
1
2024
55
0.060
 Why?
Arthritis, Rheumatoid
1
2004
105
0.060
 Why?
Particulate Matter
1
2024
54
0.060
 Why?
Folic Acid
1
2004
137
0.060
 Why?
Cytochrome P-450 CYP3A
1
2023
77
0.050
 Why?
Femur Neck
1
2003
6
0.050
 Why?
Africa South of the Sahara
1
2022
5
0.050
 Why?
Hip
1
2003
25
0.050
 Why?
Drug Delivery Systems
1
2024
143
0.050
 Why?
Bacterial Proteins
1
2006
372
0.050
 Why?
Narcotics
1
2023
108
0.050
 Why?
Quality Control
1
2003
96
0.050
 Why?
Sample Size
1
2022
37
0.050
 Why?
Eating
1
2023
157
0.050
 Why?
Breast Feeding
1
2024
187
0.050
 Why?
Vitamins
1
2022
64
0.050
 Why?
Femur
1
2003
130
0.050
 Why?
Spine
1
2003
91
0.050
 Why?
Matrix Metalloproteinase Inhibitors
1
2002
10
0.050
 Why?
Tetracycline
1
2002
20
0.050
 Why?
Radiotherapy Dosage
1
2022
246
0.050
 Why?
Vitamin D
1
2022
88
0.050
 Why?
Tretinoin
1
2002
53
0.050
 Why?
Leg
1
2022
123
0.050
 Why?
Fibroblast Growth Factor 2
2
2017
35
0.050
 Why?
Antibodies, Monoclonal
1
2005
457
0.050
 Why?
Museums
1
2021
2
0.050
 Why?
Alprostadil
1
2021
10
0.050
 Why?
Kidney
1
2005
672
0.050
 Why?
Length of Stay
1
2024
624
0.050
 Why?
Oxygen
1
2023
323
0.050
 Why?
Zimbabwe
1
2020
2
0.050
 Why?
Malawi
1
2020
10
0.040
 Why?
Wharton Jelly
1
2020
1
0.040
 Why?
Uganda
1
2020
36
0.040
 Why?
Software
1
2003
274
0.040
 Why?
Body Composition
1
2003
320
0.040
 Why?
Herpesvirus 4, Human
1
2020
39
0.040
 Why?
Cell Shape
1
2020
20
0.040
 Why?
Neisseria gonorrhoeae
1
2020
4
0.040
 Why?
Herpesviridae Infections
1
2020
53
0.040
 Why?
Ceftriaxone
1
2020
26
0.040
 Why?
Histone Deacetylase Inhibitors
1
2020
57
0.040
 Why?
B-Lymphocytes
1
2021
175
0.040
 Why?
Drug Resistance, Bacterial
1
2020
72
0.040
 Why?
Thrombocytopenia
1
2020
79
0.040
 Why?
Cohort Studies
2
2018
1403
0.040
 Why?
Remission Induction
2
2012
205
0.040
 Why?
Proctoscopy
1
2019
2
0.040
 Why?
Interleukin-6
2
2016
265
0.040
 Why?
Kaplan-Meier Estimate
1
2020
463
0.040
 Why?
Microbial Sensitivity Tests
1
2020
271
0.040
 Why?
Cell Survival
1
2020
590
0.040
 Why?
Masks
1
2018
30
0.040
 Why?
Statistics, Nonparametric
2
2013
193
0.040
 Why?
Receptors, Chemokine
1
2017
13
0.040
 Why?
Models, Animal
1
2019
227
0.040
 Why?
Neurodegenerative Diseases
1
2019
72
0.040
 Why?
Coinfection
1
2018
42
0.040
 Why?
Bone Marrow
1
2019
351
0.040
 Why?
Pandemics
1
2022
566
0.040
 Why?
Neurogenesis
1
2017
24
0.040
 Why?
Cell Separation
1
2017
89
0.040
 Why?
Cytological Techniques
1
2017
14
0.040
 Why?
Angiopoietin-2
1
2017
15
0.040
 Why?
Interleukin-2
1
2017
70
0.040
 Why?
Angiopoietin-1
1
2017
16
0.040
 Why?
Receptor, TIE-2
1
2017
16
0.040
 Why?
Axilla
1
2017
90
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2017
46
0.030
 Why?
Staining and Labeling
1
2017
97
0.030
 Why?
Fluorouracil
1
2016
55
0.030
 Why?
Gene Rearrangement
1
2017
73
0.030
 Why?
Biopsy, Needle
1
2017
182
0.030
 Why?
Odds Ratio
1
2018
548
0.030
 Why?
Neuroprotective Agents
1
2017
100
0.030
 Why?
Membrane Glycoproteins
1
2017
244
0.030
 Why?
Interferon-gamma
1
2017
176
0.030
 Why?
Chemoradiotherapy
1
2016
42
0.030
 Why?
Cord Blood Stem Cell Transplantation
1
2016
5
0.030
 Why?
Mastectomy
1
2017
141
0.030
 Why?
Directly Observed Therapy
1
2015
7
0.030
 Why?
Urine
1
2015
23
0.030
 Why?
Reagent Kits, Diagnostic
1
2015
18
0.030
 Why?
Vaginal Smears
1
2015
28
0.030
 Why?
Neovascularization, Pathologic
1
2017
153
0.030
 Why?
RNA, Viral
2
2009
124
0.030
 Why?
Neoadjuvant Therapy
1
2017
118
0.030
 Why?
Treatment Failure
1
2015
116
0.030
 Why?
Prisons
1
2015
38
0.030
 Why?
Ifosfamide
1
2015
8
0.030
 Why?
Cytarabine
1
2015
39
0.030
 Why?
Flow Cytometry
1
2017
470
0.030
 Why?
Induction Chemotherapy
1
2014
60
0.030
 Why?
Matrix Metalloproteinase 2
2
2006
58
0.030
 Why?
Receptor, Platelet-Derived Growth Factor beta
1
2013
19
0.030
 Why?
Depression
1
2019
571
0.030
 Why?
Proto-Oncogene Proteins c-kit
1
2013
36
0.030
 Why?
Melphalan
1
2014
173
0.030
 Why?
Statistics as Topic
1
2013
87
0.030
 Why?
Cancer Care Facilities
1
2013
19
0.030
 Why?
Time
1
2013
26
0.030
 Why?
Administration, Cutaneous
1
2013
53
0.030
 Why?
Infusions, Intravenous
1
2013
212
0.030
 Why?
Gene Expression Regulation
1
2017
964
0.030
 Why?
Specialization
1
2013
46
0.030
 Why?
Molecular Targeted Therapy
1
2013
121
0.030
 Why?
Demography
1
2013
93
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2013
60
0.030
 Why?
Antitrichomonal Agents
1
2012
1
0.030
 Why?
Risk Assessment
1
2017
1254
0.030
 Why?
Combined Modality Therapy
1
2014
638
0.030
 Why?
Reference Values
1
2013
302
0.030
 Why?
Polyethylene Glycols
1
2012
85
0.030
 Why?
Medical Oncology
1
2013
95
0.020
 Why?
Antigens, Viral
1
2012
43
0.020
 Why?
Administration, Topical
1
2011
56
0.020
 Why?
Single-Blind Method
1
2011
115
0.020
 Why?
Sex Factors
1
2013
691
0.020
 Why?
Neoplasm Proteins
1
2013
321
0.020
 Why?
Organ Size
1
2011
223
0.020
 Why?
Retrospective Studies
1
2022
6123
0.020
 Why?
Antibodies, Viral
1
2010
93
0.020
 Why?
Survival Rate
1
2012
905
0.020
 Why?
Anti-Retroviral Agents
1
2008
13
0.020
 Why?
Psychiatric Status Rating Scales
1
2009
322
0.020
 Why?
Psychometrics
1
2009
226
0.020
 Why?
Lectins
1
2007
14
0.020
 Why?
Busulfan
1
2008
19
0.020
 Why?
Mutation
1
2013
1292
0.020
 Why?
Glycosylation
1
2007
102
0.020
 Why?
Mice
1
2017
5658
0.020
 Why?
Ultrasonography
1
2008
429
0.020
 Why?
Maximum Tolerated Dose
1
2006
38
0.020
 Why?
Injections, Subcutaneous
1
2006
51
0.020
 Why?
Hypertension, Renal
1
2005
22
0.020
 Why?
Cell Proliferation
1
2009
986
0.020
 Why?
Fatigue
1
2006
118
0.020
 Why?
Pyridoxine
1
2004
4
0.020
 Why?
Ribonucleotides
1
2004
5
0.020
 Why?
Vitamin B 12
1
2004
27
0.010
 Why?
Recombinant Proteins
1
2006
482
0.010
 Why?
Erythrocytes
1
2004
83
0.010
 Why?
Adenosine
1
2004
70
0.010
 Why?
Homocysteine
1
2004
126
0.010
 Why?
Receptors, Interleukin-6
1
2002
22
0.010
 Why?
Endothelial Growth Factors
1
2002
9
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
13
0.010
 Why?
Lymphokines
1
2002
20
0.010
 Why?
Drug Tolerance
1
2002
59
0.010
 Why?
Safety
1
2002
77
0.010
 Why?
Child, Preschool
1
2005
3875
0.010
 Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (466) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (28) people
_
Same Department Expand Description
Search Department